PACS Group (PACS) Competitors $9.24 +0.13 (+1.37%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$9.26 +0.03 (+0.32%) As of 04/17/2025 04:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PACS vs. GH, OPCH, RDNT, PIII, BTSG, SHC, PRVA, WGS, SGRY, and CONShould you be buying PACS Group stock or one of its competitors? The main competitors of PACS Group include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), P3 Health Partners (PIII), BrightSpring Health Services (BTSG), Sotera Health (SHC), Privia Health Group (PRVA), GeneDx (WGS), Surgery Partners (SGRY), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry. PACS Group vs. Guardant Health Option Care Health RadNet P3 Health Partners BrightSpring Health Services Sotera Health Privia Health Group GeneDx Surgery Partners Concentra Group Holdings Parent Guardant Health (NASDAQ:GH) and PACS Group (NYSE:PACS) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, media sentiment, institutional ownership, profitability, community ranking, analyst recommendations and valuation. Which has better valuation and earnings, GH or PACS? PACS Group has higher revenue and earnings than Guardant Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGuardant Health$739.02M7.51-$479.45M-$3.56-12.63PACS Group$3.56B0.40$112.87MN/AN/A Do institutionals and insiders believe in GH or PACS? 92.6% of Guardant Health shares are owned by institutional investors. 5.5% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media prefer GH or PACS? In the previous week, Guardant Health had 7 more articles in the media than PACS Group. MarketBeat recorded 12 mentions for Guardant Health and 5 mentions for PACS Group. Guardant Health's average media sentiment score of 1.00 beat PACS Group's score of 0.97 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 7 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PACS Group 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor GH or PACS? Guardant Health received 274 more outperform votes than PACS Group when rated by MarketBeat users. However, 95.83% of users gave PACS Group an outperform vote while only 71.22% of users gave Guardant Health an outperform vote. CompanyUnderperformOutperformGuardant HealthOutperform Votes29771.22% Underperform Votes12028.78% PACS GroupOutperform Votes2395.83% Underperform Votes14.17% Do analysts prefer GH or PACS? Guardant Health presently has a consensus price target of $49.00, suggesting a potential upside of 8.96%. PACS Group has a consensus price target of $34.00, suggesting a potential upside of 268.16%. Given PACS Group's higher probable upside, analysts clearly believe PACS Group is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Guardant Health 0 Sell rating(s) 0 Hold rating(s) 20 Buy rating(s) 1 Strong Buy rating(s) 3.05PACS Group 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.88 Is GH or PACS more profitable? PACS Group has a net margin of 0.00% compared to Guardant Health's net margin of -59.05%. PACS Group's return on equity of 0.00% beat Guardant Health's return on equity.Company Net Margins Return on Equity Return on Assets Guardant Health-59.05% -19,157.20% -25.96% PACS Group N/A N/A N/A SummaryGuardant Health beats PACS Group on 9 of the 16 factors compared between the two stocks. Get PACS Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PACS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PACS vs. The Competition Export to ExcelMetricPACS GroupSkilled nursing care facilities IndustryMedical SectorNYSE ExchangeMarket Cap$1.41B$2.05B$5.31B$18.41BDividend YieldN/A1.43%5.45%4.18%P/E RatioN/A12.9221.9431.09Price / Sales0.400.84380.9526.55Price / CashN/A12.2638.2617.53Price / BookN/A2.776.454.30Net Income$112.87M$120.70M$3.22B$1.02B1 Month Performance-23.42%-7.04%-9.76%-8.21%1 Year Performance-60.95%-17.58%11.49%1.69% PACS Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PACSPACS Group3.2473 of 5 stars$9.24+1.4%$34.00+268.2%-59.8%$1.41B$3.56B0.0032,433High Trading VolumeGHGuardant Health3.8096 of 5 stars$45.16+3.3%$49.00+8.5%+169.8%$5.57B$739.02M-12.691,790News CoverageOPCHOption Care Health3.1502 of 5 stars$31.84+0.9%$33.00+3.6%+3.8%$5.23B$5.00B26.765,600Short Interest ↑News CoveragePositive NewsHigh Trading VolumeRDNTRadNet3.799 of 5 stars$53.36-0.1%$69.75+30.7%+4.6%$3.95B$1.83B-762.188,970News CoveragePositive NewsGap UpPIIIP3 Health Partners1.6578 of 5 stars$8.99+18.6%$0.25-97.2%-63.1%$3.23B$1.50B-10.70500Gap DownHigh Trading VolumeBTSGBrightSpring Health Services2.9819 of 5 stars$17.10+0.1%$21.67+26.7%+61.3%$2.99B$11.27B-65.7735,000News CoveragePositive NewsSHCSotera Health2.4241 of 5 stars$10.62+1.0%$15.20+43.1%-3.9%$2.98B$1.10B42.483,000News CoveragePRVAPrivia Health Group3.8958 of 5 stars$24.05-0.2%$26.87+11.7%+32.9%$2.92B$1.74B240.52810Analyst ForecastWGSGeneDx2.0418 of 5 stars$101.04+4.6%$72.33-28.4%+897.6%$2.84B$305.45M-51.551,200News CoveragePositive NewsSGRYSurgery Partners2.9071 of 5 stars$21.32+1.6%$36.63+71.8%-9.4%$2.72B$3.11B-44.4213,500News CoveragePositive NewsCONConcentra Group Holdings ParentN/A$20.86+2.8%$28.50+36.6%N/A$2.66B$1.90B13.8111,000News CoveragePositive News Related Companies and Tools Related Companies GH Alternatives OPCH Alternatives RDNT Alternatives PIII Alternatives BTSG Alternatives SHC Alternatives PRVA Alternatives WGS Alternatives SGRY Alternatives CON Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:PACS) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PACS Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PACS Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
